Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"ivacaftor"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Davies%2C+Jane+C%22&type=Person&filter%5B%5D=topic_facet%3A%22ivacaftor%22
/vufind/Search/Results?lookfor=%22Davies%2C+Jane+C%22&type=Person&filter%5B%5D=topic_facet%3A%22ivacaftor%22
Search /vufind/Search2/Results?lookfor=%22Davies%2C+Jane+C%22&type=Person&filter%5B%5D=topic_facet%3A%22ivacaftor%22
PubPharm (26)
1
Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER Trial
enthalten in:
American journal of respiratory and critical care medicine
| 2023
von
McNally, P.
|
Lester, K.
|
Stone, G.
| +25
CommentIn: Am J Respir Crit Care Med. 2023 Nov 1;208(9):911-913. - PMID 37756441
Wird geladen...
2
The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6-11 with cystic fibrosis in a real-world setting
enthalten in:
Respiratory research
| 2023
von
McNally, P.
|
Linnane, B.
|
Williamson, M.
| +9
Wird geladen...
3
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ⩾6 Years with Cystic Fibrosis and at Least One F508del Allele : A Phase 3, Open-Label Clinical Trial
enthalten in:
American journal of respiratory and critical care medicine
| 2023
von
Wainwright, C.
|
McColley, S.
|
McNally, P.
| +14
CommentIn: Am J Respir Crit Care Med. 2023 Jul 1;208(1):9-11. - PMID 37167625
Wird geladen...
4
Raised Intracranial Pressure in Three Children with Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor Modulator Therapy
enthalten in:
American journal of respiratory and critical care medicine
| 2023
von
Southern, K.
|
Barben, J.
|
Goldring, S.
| +5
Wird geladen...
5
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation : A Phase 3b, Randomized, Placebo-controlled Study
enthalten in:
American journal of respiratory and critical care medicine
| 2022
von
Mall, M.
|
Brugha, R.
|
Gartner, S.
| +21
CommentIn: Am J Respir Crit Care Med. 2022 Dec 1;206(11):1308-1310. - PMID 35947636
Wird geladen...
6
A Phase 3, open-label, 96-week trial to study the safety, tolerability, and efficacy of tezacaftor/ivacaftor in children ≥ 6 years of age homozygous for F508del or heterozygous for F508del and a residual function CFTR variant
enthalten in:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
| 2022
von
Sawicki, G.
|
Chilvers, M.
|
McNamara, J.
| +10
Wird geladen...
7
Ivacaftor in People with Cystic Fibrosis and a 3849+10kb C→T or D1152H Residual Function Mutation
enthalten in:
Annals of the American Thoracic Society
| 2021
von
Kerem, E.
|
Cohen-Cymberknoh, M.
|
Tsabari, R.
| +13
Wird geladen...
8
Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial
enthalten in:
American journal of respiratory and critical care medicine
| 2021
von
Davies, J.
|
Wainwright, C.
|
Sawicki, G.
| +7
CommentIn: Am J Respir Crit Care Med. 2021 Mar 1;203(5):536-537. - PMID 33113333
Wird geladen...
9
Entering the era of highly effective modulator therapies
enthalten in:
Pediatric pulmonology
| 2021
von
Dave, K.
|
Dobra, R.
|
Scott, S.
| +4
Wird geladen...
10
A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation
enthalten in:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
| 2021
von
Davies, J.
|
Sermet-Gaudelus, I.
|
Naehrlich, L.
| +10
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: ivacaftor
Medienart
26
Aufsätze
26
E-Artikel
26
E-Ressourcen
Zeitschriftentitel
7
American journal of respiratory and critical ca...
6
The Lancet. Respiratory medicine
5
Journal of cystic fibrosis : official journal o...
3
The New England journal of medicine
1
Annals of the American Thoracic Society
1
Expert opinion on pharmacotherapy
1
Journal of the Royal Society of Medicine
1
Pediatric pulmonology
1
Respiratory research
Alle anzeigen ...
weniger ...
Thema
ivacaftor
25
126880-72-6
25
1Y740ILL1Z
25
Cystic Fibrosis Transmembrane Conductance Regul...
24
Aminophenols
24
Journal Article
20
Quinolones
19
Research Support, Non-U.S. Gov't
15
Chloride Channel Agonists
12
Benzodioxoles
10
CFTR protein, human
10
Multicenter Study
10
tezacaftor
9
Clinical Trial, Phase III
9
Randomized Controlled Trial
6
Indoles
5
Drug Combinations
5
Ivacaftor
5
RRN67GMB0V
5
Research Support, N.I.H., Extramural
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
10
2020-
16
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
26
Englisch
Haven't found what you're looking for?
Wird geladen...